Erratum: Randomized Phase II Study of Nab-Paclitaxel and Gemcitabine With or Without Tocilizumab as First-Line Treatment in Advanced Pancreatic Cancer: Survival and Cachexia

I Inna M. Chen J Julia S. Johansen S Susann Theile (Department of Oncology, Herlev and Gentofte Hospital, Herlev, Copenhagen, Denmark) L Libbie M. Silverman K Katherine R. Pelz K Kasper Madsen O Olav Dajani K Kevin Z.M. Lim T Torben Lorentzen O Omnia Gaafer L Leonidas G. Koniaris A Anna C. Ferreira B Brian Neelon (Medical University of South Carolina, Charleston, South Carolina, United States) D Denis C. Guttridge M Michael C. Ostrowski (Department of Biochemistry and Molecular Biology and Hollings Cancer Center, Medical University of South Carolina) T Teresa A. Zimmers D Dorte Nielsen

Article Details

Volume / Issue Vol. 43, Issue 25
Published September 01, 2025
Pages 2840-2840
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (17)

I

Inna M. Chen

J

Julia S. Johansen

S

Susann Theile

Department of Oncology, Herlev and Gentofte Hospital, Herlev, Copenhagen, Denmark

L

Libbie M. Silverman

K

Katherine R. Pelz

K

Kasper Madsen

O

Olav Dajani

K

Kevin Z.M. Lim

T

Torben Lorentzen

O

Omnia Gaafer

L

Leonidas G. Koniaris

A

Anna C. Ferreira

B

Brian Neelon

Medical University of South Carolina, Charleston, South Carolina, United States

D

Denis C. Guttridge

M

Michael C. Ostrowski

Department of Biochemistry and Molecular Biology and Hollings Cancer Center, Medical University of South Carolina

T

Teresa A. Zimmers

D

Dorte Nielsen